What does international collaboration mean for you?
Posted 27th May 2020 by Liv Sewell
The present COVID-19 crisis has demonstrated the vital need for knowledge sharing across the global science community. We asked three of our speakers what international collaboration means for them as leaders in their fields.
Cell therapies: opportunities and challenges
Posted 20th May 2020 by Joshua Sewell
This article is republished with kind permission from BioVox.
Recent activities in the cell therapy field have prompted many investment funds to pour fresh and increasing capital into this space. In this review, we would like to share some observations and highlight a few of the questions that arise when new modalities cross the bridge from bench to bed.
How blockchains will transform healthcare (infographic)
Posted 15th May 2020 by Joshua Sewell
Check out this guide to learn more about the potential impact of blockchains on the medical and healthcare sectors.
An Overview of Available Preclinical Models for Non-alcoholic Fatty Liver Disease
Posted 13th May 2020 by Liv Sewell
NASH is thought to affect 25% of the global population and is a primary risk factor for Hepatocellular carcinoma (HCC) – the second most common cause of cancer deaths worldwide. Understanding the aetiology of NAFLD progression, developing non-invasive diagnostic tests and developing treatments are urgent priorities.
COVID-19 and global collaboration in science
Posted 11th May 2020 by Liv Sewell
International collaboration and travel are integral to the life of researchers and biotechnology professionals. But coronavirus has made travel impossible.
We look back over two decades of growth in international scientific collaboration to understand the extent of the effects of reduced mobility and consider what collaboration will look like in the foreseeable future.
The Biosynthesis of Cannabinoids
Posted 6th May 2020 by Joshua Sewell
We recently spoke to Jeremy Friedberg, CSO of LAVVAN, a company pioneering the biosynthesis of cannabinoids. The conversation was recorded as a podcast, which can be found here.
Digital Pathology: Lagging or Leading?
Posted 4th May 2020 by Liv Sewell
When compared to traditional methods, digital pathology may seem totally superfluous, or interesting but not all that essential. And since the costs for the elegance of digital pathology solutions are not trivial in comparison to what the peddlers traditionally have offered, it is not surprising to see the adoption curve lagging. Where then is the ‘burning platform’ that can truly drive greater adoption of digital pathology?
Understanding the gut-liver axis: implications for NAFLD prevention and treatment
Posted 29th April 2020 by Liv Sewell
You may have heard; humans are superorganisms. The human large intestine harbors tens of trillions of microbes, which equates to roughly 2 kg of cells. For reference, that’s how much your brain weighs! Within the gut microbiome, it is estimated that there are over 1,000 different species of bacteria.
